CONFIDENTIAL DATA RELEASED TO SUMMIT INCLUDED WIDE RANGE OF INFORMATION, NOT LIMITED TO VISX; TYPE OF DATA RELEASED SHOWS NO OBVIOUS MOTIVE, FDAers SAY
This article was originally published in The Gray Sheet
Executive Summary
The package of confidential FDA documents released to Summit Technology in late November 1995 contained a wide range of information, including data on Summit's main competitor Visx, ophthalmic surgeon Fred Kremer, MD, and potentially other individuals or companies.